Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982424906> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W1982424906 endingPage "1663" @default.
- W1982424906 startingPage "1661" @default.
- W1982424906 abstract "The manuscript by Reed and colleagues about the effect of glutamate and aspartate on myocardial substrate oxidation in isolated rat hearts was carried out with great biochemical expertise. The data after 30 minutes of perfusion show complete recovery of function in all perfused hearts, whether beating or arrested, with and without uptake of glutamate and aspartate. In a crystalloid preparation, there was negligible uptake of glutamate and aspartate. They observed that aspartate enters the Krebs pathway via acetyl coenzyme A; yet the standard deviation in Table III of unlabeled sources is 19 ± 18 and may not account for this offset directly. The isolated rat heart was exposed to continuous oxygenated crystalloid perfusion for 30 minutes. This lowered control oxygen consumption rate from 53 ± 10 to 22 and 17 μmol/gm dry weight. This 60% fall in small hearts is substantially lower than that in working and arrested larger dog and pig hearts, in which oxygen uptake is reduced 90%. More important, the smaller heart took up as much oxygen with potassium as with potassium plus glutamate cardioplegia, which indicates that the 95% perfusate oxygen provided sufficient nutrition to avoid ischemia when glutamate and aspartate were used and functioned well in all preparations. I presumed that no unhealthy hearts during the stabilization period were discarded for reasons cited below. Most prior studies show that glutamate/aspartate–enriched cardioplegic solution improves function in metabolism only in injured hearts. Studies of intermittent oxygenated crystalloid solution in isolated rat hearts show that uptake of glucose and branch chain acids enhanced myocardial function,1Schwalb H Izhar U Yaroslavsky E Borman JB Uretzky G. The effect of amino acids on the ischemic heart.J THORAC CARDIOVASC SURG. 1989; 98: 551-556PubMed Google Scholar delayed postischemic contracture, raised adenosine triphosphate and creatinine phosphate levels, reduced lactate dehydrogenase release after reperfusion, and confirmed this in phosphorus 31–nuclear magnetic resonance studies.2Schwalb H Kushnir T Navon G Yaroslavsky E Borman JB Uretzky G. The protective effect of enriched branched chain amino acid formulation in the ischemic heart: a phosphorus–31 nuclear magnetic resonance study.J Mol Cell Cardiol. 1987; 19: 991-998Abstract Full Text PDF PubMed Scopus (19) Google Scholar Specific amino acid effects could not be defined. The blockade of transamination by amino oxyacetate avoids the benefits of amino acids during intermittent ischemia,3Bush LR Warren S Mesh CL Lucchesi BR. Comparative effects of aspartate and glutamate during myocardial ischemia.Pharmacology. 1981; 23: 297-304Crossref PubMed Scopus (9) Google Scholar and my colleagues and I4Julia P Young HH Buckberg GD Kofsky ER Bugyi HI. Studies of myocardial protection in the immature heart. II.J THORAC CARDIOVASC SURG. 1990; 100: 888-895PubMed Google Scholar have confirmed this after hypoxia in infant dog hearts with the use of a blood cardioplegic solution. Pisarenko and coworkers,5Pisarenko OI Solomatina ES Studneva IM Ivanov VE Kapelko VI Smirnov VN. Protective effect of glutamic acid on cardiac function and metabolism during cardioplegia and reperfusion.Basic Res Cardiol. 1983; 78: 534-543Crossref PubMed Scopus (37) Google Scholar in isolated intermittently perfused rat hearts, showed that glutamate cardioplegia lessens ammonium accumulation, increases lactate utilization, and improves high-energy phosphates. Similar findings after precardioplegic ischemia were found by Kimose and associates,6Kimose HH Ravkilde J Helligso P et al.Myocardial loss of glutamate after cold chemical cardioplegia and storage in isolated blood-perfused pig hearts.Thorac Cardiovasc Surg. 1993; 41: 93-100Crossref PubMed Scopus (12) Google Scholar including the marked loss of glutamate in the reperfusate in blood-perfused hearts (to be considered subsequently). We showed augmented glutamate-aspartate uptake after brain death in dogs7Tixier D Matheis G Buckberg GD Young HH. Donor hearts with impaired hemodynamics: benefit of warm substrate enriched blood cardioplegia induction during cardiac harvesting.J THORAC CARDIOVASC SURG. 1991; 102: 207-214PubMed Google Scholar and in hypoxic infant hearts,8Julia P Young HH Buckberg GD Kofsky ER Bugyi HI. Studies of myocardial protection in the immature heart. IV. Improved tolerance of immature myocardium to hypoxia and ischemia by intravenous metabolic support.J THORAC CARDIOVASC SURG. 1991; 101: 23-32PubMed Google Scholar with no changes after blood cardioplegia without preceding ischemia. Rau and coworkers9Rau ER Shine KI Gervais A Douglas AM Amos EC. Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion.Am J Physiol. 1979; 236: H873-H879PubMed Google Scholar observed that glutamate, aspartate, arginine, and orthinine, all of which are associated with the malate-aspartate shuttle, improved posthypoxic function in rabbit hearts. This may be the primary way to transfer equivalents across the mitochondrial membrane and regulate NAD/NADH (nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide reduced form) balance. Choong and Gavin10Choong YS Gavin JB. l-Aspartate improves the functional recovery of explanted hearts sotred in St. Thomas' Hospital cardioplegic solution at 4º C.J THORAC CARDIOVASC SURG. 1990; 99: 510-517PubMed Google Scholar evaluated hypothermic St. Thomas' Hospital cardioplegic solution with l-aspartate. Storage with this solution allowed full recovery of left ventricular function and reduced sodium and calcium uptake and high-energy phosphate decline after 10 hours. The effects were extended to 20 hours with low perfusion pressure. These electrolyte effects may be important. Lazar and associates11Lazar HL Yang X Rivers S Stockwell D Shemin RJ. Superiority of substrate enhancement over oxygen free radical scavengers during extended periods of cold storage for cardiac transplantation.Surgery. 1990; 108: 423-430PubMed Google Scholar showed that adding glutamate to the storage solutions provided better results than oxygen-derived free radical scavengers (superoxide dismutase and catalase) after 5 hours2Schwalb H Kushnir T Navon G Yaroslavsky E Borman JB Uretzky G. The protective effect of enriched branched chain amino acid formulation in the ischemic heart: a phosphorus–31 nuclear magnetic resonance study.J Mol Cell Cardiol. 1987; 19: 991-998Abstract Full Text PDF PubMed Scopus (19) Google Scholar storage of rabbit hearts. Engelman and colleagues12Engelman RM Rousou JA Flack JE Iyengar J Kimura Y Das DK. Reduction of infarct size by systemic amino acid supplementation during reperfusion.J THORAC CARDIOVASC SURG. 1991; 101: 855-859PubMed Google Scholar studied regional ischemia lasting 60 minutes and showed that adding glutamate and aspartate to the cardioplegic solution produced better contractile function in the ischemic segment than in controls. We have shown this experimentally and clinically, but other electrolyte cardioplegic effects, especially hypocalcemia, may have contributed to the results. The major finding is the relative absence of citric acid effects on oxygenated perfused rat hearts with low energy requirements. Our studies confirm this with intermittent blood cardioplegia with and without amino acids. There was no change in oxygen uptake, left ventricular compliance, or contractility after 3 to 4 hours of ischemia.13Robertson JM Vinten-Johansen J Buckberg GD Follette DM Maloney Jr., JV Safety of prolonged aortic clamping with blood cardioplegia. I. Glutamate enrichment in normal hearts.J THORAC CARDIOVASC SURG. 1984; 88: 395-401PubMed Google Scholar, 14Rosenkranz ER Okamoto F Buckberg GD. The safety of prolonged aortic clamping with blood cardioplegia. II. Glutamate enrichment in energy-depleted hearts.J THORAC CARDIOVASC SURG. 1984; : 401-410Google Scholar, 15Rosenkranz ER Okamoto F Buckberg GD Robertson JM Vinten-Johansen J Bugyi HI. Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury.J THORAC CARDIOVASC SURG. 1986; 91: 428-435PubMed Google Scholar We also used only cold glutamate, and we suspect that it acted postischemically to replace Krebs cycle intermediates lost during ischemia.14Rosenkranz ER Okamoto F Buckberg GD. The safety of prolonged aortic clamping with blood cardioplegia. II. Glutamate enrichment in energy-depleted hearts.J THORAC CARDIOVASC SURG. 1984; : 401-410Google Scholar Our use is only during warm induction and reperfusion (5 minutes each). Rosenkranz and colleagues15Rosenkranz ER Okamoto F Buckberg GD Robertson JM Vinten-Johansen J Bugyi HI. Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury.J THORAC CARDIOVASC SURG. 1986; 91: 428-435PubMed Google Scholar needed to study ischemia plus 5 minutes of reperfusion to confirm that glutamate and aspartate enrichment improved initial oxygen uptake, lessened anaerobic metabolism, and restored left ventricular function nearly completely. The major change of ischemia is defined under the area of study limitations, because many urgent operations are done in patients with ischemic and reperfusion damage. Pisarenko, Lepilin, and Ivanov16Pisarenko OI Lepilin MG Ivanov VE. Cardiac metabolism and performance during L-glutamic acid infusion in postoperative cardiac failure.Clin Sci. 1986; 70: 7-1212PubMed Google Scholar demonstrated in patients receiving high-dose dopamine that glutamate changed lactate production to consumption, reduced ammonia, showed a fivefold increase in glutamate uptake, and improved cardiac function by intravenous infusion of glutamate without changing oxygen demands. No control studies with volume infusion were made. Similar data by Thomassen and colleagues17Thomassen A Nielsen TT Bagger JP Pedersen AK Henningsen P. Anti-ischemic and metabolic effects of glutamate during pacing in patients with stable angina pectoris secondary to either coronary artery disease or syndrome x.Am J Cardiol. 1991; 68: 291-295Abstract Full Text PDF PubMed Scopus (27) Google Scholar showed that intravenous glutamate reduced ischemic threshhold by pacing by decreasing ST-segment depression, lowering lactate release, reducing fatty acid content by 20%, and raising myocardial glutamate uptake by 25%. Svedjeholm and associates,18Svedjeholm R Svensson S Ekroth R et al.Trauma metabolism and the heart: studies of heart and leg amino acid flux after cardiac surgery.Thorac Cardiovasc Surg. 1990; 38: 1-5Crossref PubMed Scopus (39) Google Scholar, 19Svedjeholm R Ekroth R Joachimsson PO Ronquist G Svensson S Tyden H. Myocardial uptake of amino acids and other substrates in relation to myocardial oxygen consumption four hours after cardiac operation.J THORAC CARDIOVASC SURG. 1991; 101: 688-694PubMed Google Scholar, 20Svedjeholm R, Vanhanen I, Hakanson E, Joachimsson PO, Jorfeldt L, Nilsson L. Metabolic and hemodynamic effects of intravenous glutamate infusion early after coronary operations. J THORAC CARDIOVASC SURGIn press.Google Scholar following up patients who had coronary bypass, showed glutamate release during reperfusion. They demonstrated that intravenous glutamate with glucose-insulin-potassium increased myocardial oxygen uptake of glutamate and lactate and improved cardiac performance. The change to lactate production was presumed to be due to improvement in oxygen metabolism by glutamate. This group showed also evaluated the use of glutamate and glucose-insulin-potassium in patients with coronary disease who have depressed cardiac function. They showed that adding these components after reperfusion but during bypass allows recovery and frequently avoids inotropic intervention by improving postoperative cardiac output metabolically.21Svedjeholm R Huljebrant I Hakanson E Vanhanen I. Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations.Ann Thorac Surg. 1995; 59: S23-S30Abstract Full Text PDF PubMed Scopus (62) Google Scholar Clearly, crystalloid cardioplegic solutions are more simple and economical to use than blood solutions. They relate to specific species. Alternatively, there are no blood components (protein, erythrocytes, leukocytes, platelets), and concentrations of ions like calcium and magnesium are different from those in blood cardioplegic solutions. They also must have higher oxygen tensions, which may be detrimental. Qui and Hearse22Qiu Y Hearse DJ. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused vs. blood-perfused hearts.J THORAC CARDIOVASC SURG. 1992; 103: 960-968PubMed Google Scholar stated that blood perfusion should be used more frequently. For example, as stated in this study, insulin promotes uptake of amino acids by the heart and skeletal muscle in vitro.23Rannels DE Kao R Morgan HE. Effect of insulin on protein turnover in heart muscle.J Biol Chem. 1975; 250: 1694-1701Abstract Full Text PDF PubMed Google Scholar, 24Jefferson LS Rannels DE Munger BL Morgan HE. Insulin in the regulation of protein turnover in heart and skeletal muscle.Fed Proc. 1974; 33: 1098-1104PubMed Google Scholar Aoki25Aoki TT Brennan MF Muller WA Moore FD Cahill Jr., GF Effect of insulin on muscle glutamate uptake.J Clin Invest. 1972; 51: 2889-2894Crossref PubMed Scopus (62) Google Scholar demonstrated that uptake of glutamate by insulin occurs only in the whole blood analyses and allowed direct passage to extracellular fluids. It is possible that the literature cited related to substrate and ischemic hearts and differences in cardioplegic solution used, together with the acetyl coenzyme A, analyses may be different from the experimental and clinical effects of amino acid supplementation shown by others. The carbon 13–nuclear magnetic resonance spectroscopy is superb. It is important to repeat these studies in an in vivo blood-perfused ischemic preparation before concluding that the amino acid benefits seen by several groups are not related to augmentation of the citric acid cycle, predominantly after reperfusion, when the heart resumes aerobic work to maintain cardiac output." @default.
- W1982424906 created "2016-06-24" @default.
- W1982424906 creator A5067633921 @default.
- W1982424906 date "1996-12-01" @default.
- W1982424906 modified "2023-10-18" @default.
- W1982424906 title "Invited editorial on effects of glutamate and aspartate on myocardial substrate oxidation during potassium arrest" @default.
- W1982424906 cites W1583731893 @default.
- W1982424906 cites W1791482967 @default.
- W1982424906 cites W1998991977 @default.
- W1982424906 cites W2005636700 @default.
- W1982424906 cites W2016893071 @default.
- W1982424906 cites W2028715632 @default.
- W1982424906 cites W2034390410 @default.
- W1982424906 cites W2056281182 @default.
- W1982424906 cites W2061888859 @default.
- W1982424906 cites W2339306996 @default.
- W1982424906 cites W2403065109 @default.
- W1982424906 cites W2411315478 @default.
- W1982424906 cites W2412130884 @default.
- W1982424906 cites W2417979677 @default.
- W1982424906 cites W2430243651 @default.
- W1982424906 cites W2432693155 @default.
- W1982424906 cites W2439851536 @default.
- W1982424906 cites W2496227310 @default.
- W1982424906 cites W4321060610 @default.
- W1982424906 cites W4322388306 @default.
- W1982424906 doi "https://doi.org/10.1016/s0022-5223(96)70025-9" @default.
- W1982424906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8975858" @default.
- W1982424906 hasPublicationYear "1996" @default.
- W1982424906 type Work @default.
- W1982424906 sameAs 1982424906 @default.
- W1982424906 citedByCount "11" @default.
- W1982424906 countsByYear W19824249062013 @default.
- W1982424906 countsByYear W19824249062014 @default.
- W1982424906 countsByYear W19824249062017 @default.
- W1982424906 crossrefType "journal-article" @default.
- W1982424906 hasAuthorship W1982424906A5067633921 @default.
- W1982424906 hasBestOaLocation W19824249061 @default.
- W1982424906 hasConcept C111368507 @default.
- W1982424906 hasConcept C126322002 @default.
- W1982424906 hasConcept C127313418 @default.
- W1982424906 hasConcept C170493617 @default.
- W1982424906 hasConcept C191897082 @default.
- W1982424906 hasConcept C192562407 @default.
- W1982424906 hasConcept C2777289219 @default.
- W1982424906 hasConcept C42219234 @default.
- W1982424906 hasConcept C517785266 @default.
- W1982424906 hasConcept C61174792 @default.
- W1982424906 hasConcept C71924100 @default.
- W1982424906 hasConceptScore W1982424906C111368507 @default.
- W1982424906 hasConceptScore W1982424906C126322002 @default.
- W1982424906 hasConceptScore W1982424906C127313418 @default.
- W1982424906 hasConceptScore W1982424906C170493617 @default.
- W1982424906 hasConceptScore W1982424906C191897082 @default.
- W1982424906 hasConceptScore W1982424906C192562407 @default.
- W1982424906 hasConceptScore W1982424906C2777289219 @default.
- W1982424906 hasConceptScore W1982424906C42219234 @default.
- W1982424906 hasConceptScore W1982424906C517785266 @default.
- W1982424906 hasConceptScore W1982424906C61174792 @default.
- W1982424906 hasConceptScore W1982424906C71924100 @default.
- W1982424906 hasIssue "6" @default.
- W1982424906 hasLocation W19824249061 @default.
- W1982424906 hasLocation W19824249062 @default.
- W1982424906 hasOpenAccess W1982424906 @default.
- W1982424906 hasPrimaryLocation W19824249061 @default.
- W1982424906 hasRelatedWork W1978182363 @default.
- W1982424906 hasRelatedWork W1984770408 @default.
- W1982424906 hasRelatedWork W1992380757 @default.
- W1982424906 hasRelatedWork W2042894136 @default.
- W1982424906 hasRelatedWork W2046225343 @default.
- W1982424906 hasRelatedWork W2087339186 @default.
- W1982424906 hasRelatedWork W2410933777 @default.
- W1982424906 hasRelatedWork W2418215624 @default.
- W1982424906 hasRelatedWork W2549135832 @default.
- W1982424906 hasRelatedWork W3014690809 @default.
- W1982424906 hasVolume "112" @default.
- W1982424906 isParatext "false" @default.
- W1982424906 isRetracted "false" @default.
- W1982424906 magId "1982424906" @default.
- W1982424906 workType "article" @default.